{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:11:36Z","timestamp":1792458696831,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T00:00:00Z","timestamp":1493856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T00:00:00Z","timestamp":1493856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Although the efficacy of propranolol for the treatment of infantile hemangiomas (IHs) has been well documented, there is a paucity of clinical data regarding the safety and tolerance of propranolol in neonates. A prospective study of 51 patients less than 30 days of age with severe IH was conducted. All patients were admitted to the hospital for monitoring during initial propranolol treatment at day 0 with dose adjustments at days 7 and 28. Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), blood glucose (BG) levels and potential side effects were evaluated during treatment. There were significant decreases in mean heart rate and SBP after the initiation of propranolol therapy (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05). In contrast, no significant differences in mean DBP and BG levels were observed after each dose during hospitalization (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&gt;\u20090.05). Bradycardia and hypotension were noted in at least 1 recorded instance in 11.8% and 5.9% of patients, respectively. These hemodynamic changes were not persistent and were asymptomatic. Two patients who had a history of neonatal pneumonia reported severe bronchial hyperreactivity during treatment. This study demonstrated that propranolol administered to properly selected young infants was safe and well tolerated. However, close monitoring should be considered in high-risk young patients.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-01321-2","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T09:53:38Z","timestamp":1493373218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study"],"prefix":"10.1038","volume":"7","author":[{"given":"Yi","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,4]]},"reference":[{"key":"1321_CR1","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1542\/peds.2015-2485","volume":"136","author":"DH Darrow","year":"2015","unstructured":"Darrow, D. H., Greene, A. K., Mancini, A. J. & Nopper, A. J. Diagnosis and Management of Infantile Hemangioma. Pediatrics \n                           136, e1060\u2013104 (2015).","journal-title":"Pediatrics"},{"key":"1321_CR2","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/archderm.140.8.963","volume":"140","author":"ME George","year":"2004","unstructured":"George, M. E., Sharma, V., Jacobson, J., Simon, S. & Nopper, A. J. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol \n                           140, 963\u2013969 (2004).","journal-title":"Arch Dermatol"},{"key":"1321_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1542\/peds.2012-1128","volume":"131","author":"TS Chen","year":"2013","unstructured":"Chen, T. S., Eichenfield, L. F. & Friedlander, S. F. Infantile hemangiomas: an update on pathogenesis and therapy. Pediatrics \n                           131, 99\u2013108 (2013).","journal-title":"Pediatrics"},{"key":"1321_CR4","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1056\/NEJMc0708819","volume":"358","author":"C Leaute-Labreze","year":"2008","unstructured":"Leaute-Labreze, C. et al. Propranolol for severe hemangiomas of infancy. N Engl J Med \n                           358, 2649\u20132651 (2008).","journal-title":"N Engl J Med"},{"key":"1321_CR5","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1542\/peds.2010-0029","volume":"128","author":"M Hogeling","year":"2011","unstructured":"Hogeling, M., Adams, S. & Wargon, O. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics \n                           128, e259\u2013e266 (2011).","journal-title":"Pediatrics"},{"key":"1321_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C Leaute-Labreze","year":"2015","unstructured":"Leaute-Labreze, C. et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med \n                           372, 735\u201346 (2015).","journal-title":"N Engl J Med"},{"key":"1321_CR7","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1001\/archdermatol.2011.203","volume":"147","author":"CJ Price","year":"2011","unstructured":"Price, C. J. et al. Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. Arch Dermatol \n                           147, 1371\u20131376 (2011).","journal-title":"Arch Dermatol"},{"key":"1321_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/PRS.0b013e31827c6fab","volume":"131","author":"A Izadpanah","year":"2013","unstructured":"Izadpanah, A., Izadpanah, A., Kanevsky, J., Belzile, E. & Schwarz, K. Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta-analysis. Plast Reconstr Surg \n                           131, 601\u2013613 (2013).","journal-title":"Plast Reconstr Surg"},{"key":"1321_CR9","doi-asserted-by":"publisher","first-page":"31744","DOI":"10.1038\/srep31744","volume":"6","author":"Y Ji","year":"2016","unstructured":"Ji, Y. et al. Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study. Sci Rep \n                           6, 31744 (2016).","journal-title":"Sci Rep"},{"key":"1321_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1542\/peds.2007-2767","volume":"122","author":"LC Chang","year":"2008","unstructured":"Chang, L. C. et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics \n                           122, 360\u2013367 (2008).","journal-title":"Pediatrics"},{"key":"1321_CR11","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1542\/peds.2011-3683","volume":"130","author":"MM Tollefson","year":"2012","unstructured":"Tollefson, M. M. & Frieden, I. J. Early growth of infantile hemangiomas: what parents\u2019 photographs tell us. Pediatrics \n                           130, e314\u2013e320 (2012).","journal-title":"Pediatrics"},{"key":"1321_CR12","doi-asserted-by":"publisher","first-page":"e3908","DOI":"10.1097\/MD.0000000000003908","volume":"95","author":"Y Ji","year":"2016","unstructured":"Ji, Y. et al. Oral atenolol therapy for proliferating infantile hemangioma: A prospective study. Medicine (Baltimore) \n                           95, e3908 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"1321_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/SCS.0000000000002206","volume":"27","author":"ZM MacIsaac","year":"2016","unstructured":"MacIsaac, Z. M. et al. Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas. J Craniofac Surg \n                           27, 159\u2013162 (2016).","journal-title":"J Craniofac Surg"},{"key":"1321_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jaad.2010.06.048","volume":"65","author":"M de Graaf","year":"2011","unstructured":"de Graaf, M. et al. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants. J Am Acad Dermatol \n                           65, 320\u2013327 (2011).","journal-title":"J Am Acad Dermatol"},{"key":"1321_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jama.2015.13969","volume":"315","author":"S Prey","year":"2016","unstructured":"Prey, S. et al. Safety of Propranolol Therapy for Severe Infantile Hemangioma. JAMA \n                           315, 413\u2013415 (2016).","journal-title":"JAMA"},{"key":"1321_CR16","first-page":"450","volume":"52","author":"A Erbay","year":"2010","unstructured":"Erbay, A. et al. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants. Turk J Pediatr \n                           52, 450\u2013456 (2010).","journal-title":"Turk J Pediatr"},{"key":"1321_CR17","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/1346-8138.13029","volume":"42","author":"L Li","year":"2015","unstructured":"Li, L. & Ma, L. Use of propranolol on a nasal hemangioma in an extremely low birthweight premature infant. J Dermatol \n                           42, 1101\u20131102 (2015).","journal-title":"J Dermatol"},{"key":"1321_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1053\/j.semperi.2003.11.004","volume":"28","author":"JE Jones","year":"2004","unstructured":"Jones, J. E. & Jose, P. A. Neonatal blood pressure regulation. Semin Perinatol \n                           28, 141\u2013148 (2004).","journal-title":"Semin Perinatol"},{"key":"1321_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1136\/bmj.308.6924.298","volume":"308","author":"RS Levine","year":"1994","unstructured":"Levine, R. S., Hennekens, C. H. & Jesse, M. J. Blood pressure in prospective population based cohort of newborn and infant twins. BMJ \n                           308, 298\u2013302 (1994).","journal-title":"BMJ"},{"key":"1321_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1058-9813(00)00032-1","volume":"11","author":"MS Miller","year":"2000","unstructured":"Miller, M. S., Shannon, K. M. & Wetzel, G. T. Neonatal bradycardia. Prog Pediatr Cardiol \n                           11, 19\u201324 (2000).","journal-title":"Prog Pediatr Cardiol"},{"key":"1321_CR21","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1136\/adc.63.11.1386","volume":"63","author":"TH Koh","year":"1988","unstructured":"Koh, T. H., Eyre, J. A. & Aynsley-Green, A. Neonatal hypoglycaemia\u2013the controversy regarding definition. Arch Dis Child \n                           63, 1386\u20131388 (1988).","journal-title":"Arch Dis Child"},{"key":"1321_CR22","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1097\/PRS.0b013e318208d2ac","volume":"127","author":"CG Bauland","year":"2011","unstructured":"Bauland, C. G., Luning, T. H., Smit, J. M., Zeebregts, C. J. & Spauwen, P. H. Untreated hemangiomas: growth pattern and residual lesions. Plast Reconstr Surg \n                           127, 1643\u20131648 (2011).","journal-title":"Plast Reconstr Surg"},{"key":"1321_CR23","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1542\/peds.2006-0413","volume":"118","author":"AN Haggstrom","year":"2006","unstructured":"Haggstrom, A. N. et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics \n                           118, 882\u2013887 (2006).","journal-title":"Pediatrics"},{"key":"1321_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/bjd.13250","volume":"172","author":"H Song","year":"2015","unstructured":"Song, H. et al. Safety profile of a divided dose of propranolol for heart rate in children with infantile haemangioma during 16 weeks of treatment. Br J Dermatol \n                           172, 444\u2013449 (2015).","journal-title":"Br J Dermatol"},{"key":"1321_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bjd.13388","volume":"172","author":"Y Ji","year":"2015","unstructured":"Ji, Y., Chen, S., Xu, C., Li, L. & Xiang, B. The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action. Br J Dermatol \n                           172, 24\u201332 (2015).","journal-title":"Br J Dermatol"},{"key":"1321_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ajd.12079","volume":"54","author":"G Frost","year":"2013","unstructured":"Frost, G. & Relic, J. Dangers of propranolol in preterm infants. Australas J Dermatol \n                           54, 237\u2013238 (2013).","journal-title":"Australas J Dermatol"},{"key":"1321_CR27","doi-asserted-by":"publisher","first-page":"F85","DOI":"10.1136\/archdischild-2014-306197","volume":"100","author":"R Goelz","year":"2015","unstructured":"Goelz, R. & Poets, C. F. Incidence and treatment of infantile haemangioma in preterm infants. Arch Dis Child Fetal Neonatal Ed \n                           100, F85\u201391 (2015).","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"1321_CR28","first-page":"821","volume":"137","author":"WL Castleman","year":"1990","unstructured":"Castleman, W. L., Sorkness, R. L., Lemanske, R. J. & McAllister, P. K. Viral bronchiolitis during early life induces increased numbers of bronchiolar mast cells and airway hyperresponsiveness. Am J Pathol \n                           137, 821\u2013831 (1990).","journal-title":"Am J Pathol"},{"key":"1321_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archpedi.1994.02170100077015","volume":"148","author":"M Korppi","year":"1994","unstructured":"Korppi, M. et al. Bronchial asthma and hyperreactivity after early childhood bronchiolitis or pneumonia. An 8-year follow-up study. Arch Pediatr Adolesc Med \n                           148, 1079\u20131084 (1994).","journal-title":"Arch Pediatr Adolesc Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01321-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01321-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01321-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T22:57:34Z","timestamp":1671749854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01321-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,4]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-01321-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,4]]},"assertion":[{"value":"26 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1503"}}